Barrow Opens Treatment Center For Lou Gehrig's Disease

January 15, 2014

Barrow Neurological Institute at St. Joseph’s Hospital is opening a new center to focus on research and treatment of Lou Gehrig’s disease.

The 32,000-square-foot center will provide treatment for ALS and other neuromuscular diseases, like muscular dystrophy and multiple sclerosis.

The center is expected to improve the quality of life for patients and family members and pave the way for the future of ALS research.

ALS is a progressive and neurodegenerative disease in which the cells that control voluntary muscle movements die, leading to paralysis and ultimately death, usually within 3-to-5 years. 

The new center will integrate researchers and medical staff to work side-by-side with patients in developing treatments for the disease.

The Gregory Fulton Center was primarily funded by a $2.7 million donation from Ira and Mary Lou Fulton, whose son Gregory died from ALS in 2011.